Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review

The latest issue of JAMA features a groundbreaking paper written by Romain Pirracchio, MD, MPH, PhD; Balasubramanian Venkatesh, MD; and Matthieu Legrand, MD, PhD, promising profound implications for clinical practice. 

"Severe pulmonary infections, including COVID-19, community-acquired pneumonia, influenza, and Pneumocystis pneumonia, are a leading cause of death among adults worldwide. Pulmonary infections in critically ill patients may cause septic shock, acute respiratory distress syndrome, or both, which are associated with mortality rates ranging between 30% and 50%."

To read the whole article, visit here